𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1

✍ Scribed by Chun Kiat Lee; Hong Kai Lee; Tze Ping Loh; Sunil Kumar Sethi; Evelyn Siew-Chuan Koay; Julian Wei-Tze Tang

Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
107 KB
Volume
84
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Genotyping for HIV drug resistance is costly and beyond the means for many Southeast Asian patients, who are self‐funded. This prompted the development of a more cost‐effective, in‐house assay for an ethnically diverse, Southeast Asian population at the National University Hospital in Singapore, using Sanger‐based sequencing. Plasma samples from 20 treatment‐failure patients with a broad spectrum of HIV drug resistance mutations were used to validate this assay clinically. Blinded testing gave concordant results for 7/7 (100%) protease drug resistance‐related mutations, including one major and six minor mutations, and 111/116 (95.7%) reverse‐transcriptase (RT) drug resistance‐related mutations, including 65 nucleoside RT inhibitors (NRTI) and 46 non‐nucleoside RT inhibitors (NNRTI) mutations. There were five discordant results, involving three NRTI‐ and two NNRTI‐resistance‐associated mutations. Highly conserved primers designed to have a wide coverage of the HIV pol gene (covering the entire protease and 395 codons of the RT region) enabled efficient multi‐ethnic population‐based genotyping. Reagents for this in‐house test cost around 60% less than those for commercially available assays (SGD150 vs. SGD350 per sample). In addition, this assay also identified mutations located within the C‐terminal domain (codons 312–560) of RT that are beyond the reach of most published and commercial GRTs. Currently, most research on C‐terminal drug‐resistance‐related mutations has been conducted on HIV subtype B infections. Therefore this assay enables further study of these C‐terminal mutations in Southeast Asian populations, where there is a high prevalence of CRF01_AE and other non‐subtype B HIV infections. J. Med. Virol. 84:394–401, 2012. © 2011 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

A microtitre format point mutation assay
A microtitre format point mutation assay: Application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine
✍ Steve Kaye; Clive Loveday; Richard S. Tedder 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 1 views

## Abstract An assay for the analysis of point mutations in DNA fragments amplified by the polymerase chain reaction is described. The method was applied to the analysis of mutations leading to single amino acid changes in the reverse transcriptase gene of human immunodeficiency virus type‐1 that a

Analysis of drug resistance-associated m
Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union
✍ E. Vázquez de Parga; A. Rakhmanova; L. Pérez-Álvarez; A. Vinogradova; E. Delgado 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

## Abstract There are few data on drug resistance‐associated mutations in the former Soviet Union since, studies have usually been focused on the __env__ or __gag__ genes for subtype information. This study examines the prevalence and patterns of resistance‐associated mutations to reverse transcrip

Detection of drug resistance mutations a
Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml
✍ Chris Verhofstede; Filip Van Wanzeele; Bea Van Der Gucht; Jolanda Pelgrom; Linos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA levels of less than 1,000 copies (c)/ml, genotyping was performed on 39 samples from patients on highly active antiretroviral therapy (HAART) showing a viremia of over 50 c/ml up to a max

Drug resistance mutations and newly reco
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients
✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an